Bharat Biotech announces Phase III results of COVAXIN EP News Bureau Mar 3, 2021 Bharat Biotech has announced the first interim analysis of its BBV152 (COVAXIN). The whole virion inactivated COVID-19 vaccine…
COVAXIN to boost immune response, longer-lasting immunity with ViroVax’s adjuvant EP News Bureau Oct 5, 2020 Bharat Biotech has announced its novel coronavirus vaccine COVAXIN approved for human trials, will use adjuvant Alhydroxiquim-II…
